{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "9483747", "DateCompleted": {"Year": "1998", "Month": "05", "Day": "01"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["rus"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0040-3660", "JournalIssue": {"Volume": "69", "Issue": "11", "PubDate": {"Year": "1997"}}, "Title": "Terapevticheskii arkhiv", "ISOAbbreviation": "Ter Arkh"}, "ArticleTitle": "[The action of blood ozonization on the course of progressive pulmonary tuberculosis combined with diabetes mellitus].", "Pagination": {"StartPage": "44", "EndPage": "48", "MedlinePgn": "44-8"}, "Abstract": {"AbstractText": ["A course intravenous injection of dissolved ozone to patients with rapidly progressing lung tuberculosis associated with diabetes mellitus in resistance to antituberculous drugs for 3-4 weeks eliminates this resistance and reduces bacterial discharge including polyresistant strains (MDR-tuberculosis). The percentage of closed caverns significantly increased. Mechanisms of etiopathogenic impact of parenteral dissolved ozone are discussed."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Belianin", "ForeName": "I I", "Initials": "II"}], "PublicationTypeList": ["Case Reports", "Comparative Study", "English Abstract", "Journal Article"], "VernacularTitle": "Vozde\u012dstvie ozonirovaniia krovi na techenie progressiruiushchego tuberkuleza legkikh, sochetaiushchegosia s sakharnym diabetom."}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Ter Arkh", "NlmUniqueID": "2984818R", "ISSNLinking": "0040-3660"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": [], "DescriptorName": "Diabetes Complications"}, {"QualifierName": ["blood"], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": [], "DescriptorName": "Disease Progression"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Infusions, Intravenous"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["isolation & purification"], "DescriptorName": "Mycobacterium tuberculosis"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Ozone"}, {"QualifierName": ["microbiology"], "DescriptorName": "Sputum"}, {"QualifierName": ["blood", "drug therapy", "microbiology"], "DescriptorName": "Tuberculosis, Pulmonary"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1997", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}, {"Year": "1998", "Month": "3", "Day": "4", "Hour": "0", "Minute": "1"}, {"Year": "1997", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9483747"]}}], "PubmedBookArticle": []}